Stock Code: 002524 Stock Abbreviation: Guangzheng Eye
Guangzheng Eye Hospital Group Co., Ltd.
2026 Restricted Stock Incentive Plan
(Draft)
July 2026
Statement
The Company and all directors guarantee that this incentive plan and its summary contain no false records, misleading statements, or major omissions, and bear individual and joint legal responsibility for their authenticity, accuracy, and completeness.
Special Notice
-
This incentive plan is formulated in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for Equity Incentives of Listed Companies, the Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 1 - Business Handling, the Articles of Association of Guangzheng Eye Hospital Group Co., Ltd., and other relevant laws, regulations, and normative documents.
-
Guangzheng Eye Hospital Group Co., Ltd. (hereinafter referred to as "Guangzheng Eye" or the "Company") does not have any of the circumstances stipulated in Article 7 of the Administrative Measures for Equity Incentives of Listed Companies that prohibit the implementation of equity incentives:
(1) The financial accounting report for the most recent fiscal year was issued with an adverse opinion or a disclaimer of opinion by a certified public accountant;
(2) The internal control of the financial report for the most recent fiscal year was issued with an adverse opinion or a disclaimer of opinion by a certified public accountant;
(3) Failure to distribute profits in accordance with laws, regulations, the Articles of Association, or public commitments within the last 36 months after listing;
(4) Other circumstances where equity incentives are prohibited by laws and regulations;
(5) Other circumstances recognized by the China Securities Regulatory Commission (CSRC).
- The participants of this incentive plan do not have any of the circumstances stipulated in Article 8 of the Administrative Measures for Equity Incentives of Listed Companies that prohibit them from becoming participants:
(1) Being identified as an inappropriate candidate by a stock exchange within the last 12 months;
(2) Being identified as an inappropriate candidate by the CSRC and its dispatched agencies within the last 12 months;
(3) Having been subject to administrative penalties or market entry bans by the CSRC and its dispatched agencies within the last 12 months due to major violations of laws and regulations;
(4) Having circumstances stipulated by the Company Law of the People's Republic of China that prohibit one from serving as a director or senior manager of the company;
(5) Being prohibited from participating in equity incentives of listed companies by laws and regulations;
(6) Other circumstances recognized by the CSRC.
-
The source of the restricted shares for this incentive plan is the Guangzheng Eye A-share common stock repurchased by the Company from the secondary market.
-
The total number of restricted shares to be granted under this incentive plan shall not exceed 1.5 million shares, accounting for approximately 0.29% of the Company's total share capital of 515.331574 million shares at the time of the announcement of this draft. This incentive plan is a one-time grant with no reserved shares.
As of the announcement date of this draft, the Company's effective equity incentive plan is the 2023 Restricted Stock Incentive Plan. The restricted shares registered under the initial and reserved grants of the 2023 plan total 2.922 million shares (excluding those already unlocked and repurchased/cancelled), accounting for 0.57% of the Company's total share capital of 515.331574 million shares at the time of this draft's announcement. The total number of underlying shares involved in all effective equity incentive plans does not exceed 10% of the Company's total share capital. The cumulative number of company shares granted to any single participant through all effective equity incentive plans does not exceed 1% of the Company's total share capital.